• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; MOZ Back to Search Results
Lot Number 8RSL028
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aspiration/Inhalation (1725); Arthralgia (2355); Joint Swelling (2356); No Code Available (3191)
Event Date 01/01/2018
Event Type  Injury  
Event Description
Peritonitis [peritonitis] ; problems between skin and organs with burning sensation/ as if it were a herniation [burning sensation] ; impaired healing [impaired healing] ; recurrent abdominal distension/swollen stomach [abdominal distension] ; recurrent constipation [constipation] ; vomiting [vomiting] ; recurrent abdominal pain [abdominal pain] ; fever [fever] ; allergic reaction [allergic reaction].Case narrative: upon internal review on 05-dec-2018, this case initially considered as non-serious was updated to serious as the medically significant event of peritonitis was added.This case is related to case id: (b)(6) (duplicate).Initial information received on (b)(6) 2018 regarding an unsolicited valid non-serious case received from a patient from united states.This case involves an adult female patient who was treated with carboxymethylcellulose, sodium hyaluronate (seprafilm) and after unknown latency experienced problems between skin and organs with burning sensation/ as if it were a herniation, impaired healing, recurrent abdominal distension/swollen stomach, peritonitis, allergic reaction, recurrent constipation, vomiting, recurrent abdominal pain and fever.The patient's past medical treatment(s), history, vaccination(s) and family history were not provided.On an unknown date in 2016, the patient was implanted with carboxymethylcellulose, sodium hyaluronate sheet after bowel obstruction surgery in context of an intestinal occlusion.On an unknown date in 2016, after the surgery, patient reported problems between skin and organs with burning sensation, impaired healing, vomiting and fever since seprafilm insertion.On an unknown date, after unknown latency, patient also presented with recurrent episodes of adverse events, in particular after some meals: abdominal distention/swollen stomach, allergic reaction, peritonitis, abdominal pain, constipation and no diarrhea.On (b)(6) 2018, she would have an appointment with a surgeon about these disorders.Final diagnosis was fever, recurrent abdominal pain, vomiting, recurrent constipation, recurrent abdominal distention/swollen stomach, allergic reaction, peritonitis, impaired healing and problems between skin and organs with burning sensation/ as if it were a herniation.It was not reported if the patient received a corrective treatment.The patient outcome is reported as not recovered / not resolved on an unknown date for problems between skin and organs with burning sensation/ as if it were a herniation, impaired healing, vomiting, fever, abdominal distension/swollen stomach, allergic reaction, peritonitis and unknown for abdominal pain and constipation.Seriousness criteria: medically significant for peritonitis a product technical complaint was initiated with results pending for the same.Upon internal review on 05-dec-2018, this case was identified as duplicate of case id: (b)(6) and all the information from case id (b)(6) was merged into this case.The case was upgraded to serious.Additional events of allergic reaction and peritonitis were added along with details.The event term abdominal distension was updated to abdominal distension/swollen stomach and outcome was updated from unknown to not recovered.Indication of seprafilm was added.Related case was added.Clinical course was updated and text was amended accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
MOZ
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleasantview terrace
ridgefield NJ 07657
Manufacturer (Section G)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleasantview terrace
ridgefield NJ 07657
Manufacturer Contact
darlene kadel
55 corporate drive, ms 55b-220
a
bridgewater, NJ 08807
MDR Report Key8176324
MDR Text Key130985511
Report Number2246315-2018-00724
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2021
Device Lot Number8RSL028
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
-
-